Rare Diseases

Why Canada needs a clear policy on orphan drugs

Larry Lynd is lead investigator of the CIHR New Emerging Team for Rare Diseases at the University of British Columbia. Peter Klein is a member of the research team and led a group of UBC journalism students who produced Million Dollar Meds, a Web portal about orphan drugs.

Click here to read the full article from the February 29, 2016 Special Edition Edition to The Globe and Mail